Adam Koppel
@Bain Capital Life Sciences Investors, Llc
Latest period2024 - Q3ReportedManaged Assets$961.176MTotal holdings24
Assets growth rate5.53%Assets growth rate (2-Q avg)-10.63%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Bain Capital Life Sciences Investors, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 24 positions.
Assets under management
The assets under management (AUM) of Bain Capital Life Sciences Investors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 961.176M in assets, with a quarterly growth rate of 5.53% and a 2-quarter average growth rate of -10.63%. The portfolio is managed by Adam Koppel, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CDTXCidara Therapeutics Inc
| 0.79% | $7.558M 703,080 shares@ $10.75 avg price | New Position |